3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasm Metastasis
1
Endometrial Neoplasms
1
Interventions
Cyclophosphamide
4
trastuzumab deruxtecan
3
fludarabine
3
Standard of Care
3
Injections
3
Cisplatin
3
Bevacizumab
3
toripalimab
2
sacituzumab govitecan
2
pembrolizumab
2
fludarabine phosphate
2
Specimen Handling
2
Radiosurgery
2
Pemetrexed
2
Palliative Care
2
Gemcitabine
2
Fulvestrant
2
Fluorouracil
2
Docetaxel
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
vedolizumab
1
tislelizumab
1
sintilimab
1
lobaplatin
1
lenvatinib
1
ivosidenib
1
irinotecan sucrosofate
1
exemestane
1
eribulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasm Metastasis
×
Diet, Plant-Based
×
Clear all
NCT07189702
2026-04-08
BEND-MBEC
University of Rochester
Phase NA
Not yet recruiting
60 enrolled